E2O Stock Overview
A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
STRATA Skin Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.76 |
| 52 Week High | US$6.95 |
| 52 Week Low | US$2.74 |
| Beta | 1.37 |
| 11 Month Change | 0% |
| 3 Month Change | 24.50% |
| 1 Year Change | -37.33% |
| 33 Year Change | -67.86% |
| 5 Year Change | -79.77% |
| Change since IPO | -99.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| E2O | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 3.6% | 1.5% |
| 1Y | -37.3% | 3.6% | 12.6% |
Return vs Industry: E2O underperformed the German Medical Equipment industry which returned 8.2% over the past year.
Return vs Market: E2O underperformed the German Market which returned 6.2% over the past year.
Price Volatility
| E2O volatility | |
|---|---|
| E2O Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: E2O has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine E2O's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 99 | Dolev Rafaeli | www.strataskinsciences.com |
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions.
STRATA Skin Sciences, Inc. Fundamentals Summary
| E2O fundamental statistics | |
|---|---|
| Market cap | €13.07m |
| Earnings (TTM) | -€7.52m |
| Revenue (TTM) | €29.61m |
0.4x
P/S Ratio-1.7x
P/E RatioIs E2O overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E2O income statement (TTM) | |
|---|---|
| Revenue | US$32.73m |
| Cost of Revenue | US$14.96m |
| Gross Profit | US$17.77m |
| Other Expenses | US$26.09m |
| Earnings | -US$8.31m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.99 |
| Gross Margin | 54.30% |
| Net Profit Margin | -25.40% |
| Debt/Equity Ratio | 159.2% |
How did E2O perform over the long term?
See historical performance and comparison